In the context of lung and gastric cancers, WBP2 has been shown to negatively regulate LATS1 and LATS2 kinase activity through WW domain-dependent and WW domain-independent mechanisms, respectively [71,72]. This evidence concerns the gene LATS1 and gastric cancer.